Amber Ophthalmics

Trefoil Therapeutics

The company develops engineered protein therapies to treat corneal endothelial and epithelial diseases for patients with vision loss or ocular surface damage.

Claris Bio

This biotechnology company develops topical therapies for patients with orphan ophthalmic disorders and corneal diseases including limbal stem cell deficiency.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

Azura Ophthalmics

This biopharmaceutical company develops ophthalmic keratolytics to treat patients suffering from meibomian gland dysfunction and other ocular surface diseases.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

StemSight

This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.